Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Midatech Pharma plc (MTP)

1.54   -0.02 (-1.28%) 11-28 09:34
Open: 1.45 Pre. Close: 1.56
High: 1.54 Low: 1.45
Volume: 1,972 Market Cap: 6(M)

Technical analysis

as of: 2022-11-28 9:50:32 AM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.04     One year: 2.38
Support: Support1: 1.28    Support2: 1.07
Resistance: Resistance1: 1.75    Resistance2: 2.03
Pivot: 1.6
Moving Average: MA(5): 1.55     MA(20): 1.66
MA(100): 2.69     MA(250): 3.67
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 32.8     %D(3): 34.5
RSI: RSI(14): 38.6
52-week: High: 7.44  Low: 0.49
Average Vol(K): 3-Month: 26 (K)  10-Days: 8 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MTP ] has closed above bottom band by 31.8%. Bollinger Bands are 70.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 31 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.53 - 1.54 1.54 - 1.55
Low: 1.5 - 1.51 1.51 - 1.52
Close: 1.51 - 1.53 1.53 - 1.54

Company Description

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Headline News

Sun, 27 Nov 2022
Watch Meet the Press Excerpt: MTP Compressed: Polis calls for a national and local gun response - NBC Insider

Wed, 23 Nov 2022
Take action on illegal buildings in Amritsar, MTP Dept told - The Tribune India

Sun, 20 Nov 2022
Why India's Laws Make Abortion Traumatic & Dangerous For Minors — Article 14 - Article 14

Thu, 10 Nov 2022
MTP Hits the Green River Trail, Preps for Winter Build-a-Bike - Cascade Bicycle Club

Wed, 09 Nov 2022
Kowitt Awarded K01 to Help Communicate Harms of Multiple Tobacco Products to Youth | Newsroom - UNC Health and UNC School of Medicine

Sun, 06 Nov 2022
Watch Meet the Press Excerpt: MTP Compressed: Republicans confident as Democrats say they’re ‘responsible’ but ‘not perfect’ ahead of Election Day - NBC Insider

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 4 (M)
% Held by Insiders 3.42e+006 (%)
% Held by Institutions 0 (%)
Shares Short 3 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -7.35e+006
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 169.3
Return on Equity (ttm) -52.5
Qtrly Rev. Growth 645000
Gross Profit (p.s.) 10.77
Sales Per Share -61.6
EBITDA (p.s.) 372903
Qtrly Earnings Growth -0.5
Operating Cash Flow 0 (M)
Levered Free Cash Flow -6 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.03
Price to Cash Flow 1.25

Stock Dividends

Dividend 0
Forward Dividend 8180
Dividend Yield 0%
Dividend Pay Date 2020-03-02
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.